Healthy Living Institute – Self-Care and Coping With Bipolar Disorder and Depression
from Living With Bipolar Disorder and Manic Depression
Price: USD 0.99
View Details about Healthy Living Institute
Why people with bipolar disorder are bigger risk-takers
The study by the Universities of Manchester and Liverpool, published today [Wednesday 9 July] in the journal Brain, used brain imaging to identify neural pathways that are responsible for the symptoms of the disorder. The findings will help to design …
Read more on Medical Xpress
Mental-health App Can Predict Well-being
By passively analyzing mobile data, the app can detect if a patient with mental illness — such as depression, anxiety and bipolar disorders or schizophrenia — is acting symptomatic. Symptoms may include lethargy (decreased movement captured by motion …
Read more on Laboratory Equipment
Research and Markets: Bipolar Disorder (Manic Depression) Global Clinical …
Our clinical trial report, Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014" provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides elemental information and data relating to …
Read more on Business Wire (press release)
Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014 …
[USPRwire, Wed Jul 02 2014] GlobalData's clinical trial report, "Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014" provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides …
Read more on USPRwire (press release)
Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014
FOR IMMEDIATE RELEASE, Illinois – United States – June 30,2014 (PR Carbon): Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014 is a new market research publication announced by Reportstack. This report provides data on the …
Read more on PR Carbon (press release)
Malibu, CA (PRWEB) June 09, 2014
Bridges to Recovery, the leading Residential treatment for OCD in Malibu, has announced a new groundbreaking OCD treatment plan that combines the latest in research and treatment techniques with traditional treatment plans in a luxurious residential environment.
Bridges to Recovery is a fully licensed dual diagnosis residential treatment center that specializes in treating bipolar disorder, depression, OCD, mood disorders, and any other mental disorder. Bridges to Recovery has been licensed since 2002, and has been dedicated to delivering the highest level of care possible. Bridges to Recovery and theyre innovative techniques are true pioneers in residential treatment mental health care.
Bridges to Recovery facilities are licensed as short-term residential treatment facilities by the department of Social Services and our programs are certified by the Department of Mental Health in California. This ensures the highest level of care in a comfortable residential setting. For many clients we provide an alternative to a traditional hospitalization.
More information about Bridges to Recovery and their groundbreaking treatment plans is available online at http://www.bridgestorecovery.com or by calling (877) 386-3398.
Risperdal Breast-Growth Attorney: Resource4thePeople Lawyers Reviewing Breast-Growth Allegations Involving both Men and Boys
San Diego, CA (PRWEB) April 08, 2014
Resource4thePeople announced today that its national network of attorneys has expanded its free legal consultations over allegations that the antipsychotic medication Risperdal may cause a breast-growth condition known as gynecomastia or other side effects.
These consultations now encompass claims from both boys and men who may have been affected by non-approved uses of the medication as recently outlined* by the U.S. Justice Department and the Food and Drug Administration involving multimillion dollar criminal and civil penalties.
As detailed by the FDA and Justice Department officials off-label uses of Risperdal were admitted by the manufacturers of Risperdal and both boys and men were affected by the illegal activities to which the companies pleaded guilty,” said Resource4thePeople.
“Therefore our national network of attorneys is extending its offer involving these compensations involving gynecomastia and other serious side effects to include males of all ages.
The Justice Department and FDA issued a joint Nov. 4, 2013 press release* in which they explained the resolution of charges against pharmaceutical giant Johnson & Johnson and its subsidiaries in connection with Risperdal and other medications:
Global health care giant Johnson & Johnson (J&J) and its subsidiaries will pay more than $ 2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to the nations largest long-term care pharmacy provider. The global resolution is one of the largest health care fraud settlements in U.S. history, including criminal fines and forfeiture totaling $ 485 million and civil settlements with the federal government and states totaling $ 1.72 billion.
The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust, said Attorney General Eric Holder. This multibillion-dollar resolution demonstrates the Justice Departments firm commitment to preventing and combating all forms of health care fraud. And it proves our determination to hold accountable any corporation that breaks the law and enriches its bottom line at the expense of the American people.
The resolution includes criminal fines and forfeiture for violations of the law and civil settlements based on the False Claims Act arising out of multiple investigations of the company and its subsidiaries.
Resource4thePeople said its attorneys are investigating cases in which off-label uses of Risperdal resulted in a diagnosis of diabetes or tardive dyskinesia and gynecomastia (male breast development).
The Food and Drug Administration originally approved Risperdal in 1993 for the treatment of schizophrenia, although that approval later was expanded to also address bi-polar disorder.
Risperdal works by blocking dopamine, which releases prolactin from the pituitary gland. Thus, Risperdal creates a sedating effect on the patient, typical in antipsychotics of its class. It can be administered orally in the form of tablets or via a bi-weekly injection.
When companies put profit over patients health and misuse taxpayer dollars, we demand accountability,” said Associate Attorney General Tony West.
The Justice Department in its press release said that from March 3, 2002, through Dec. 31, 2003, Janssen Pharmaceuticals Inc., a J&J subsidiary, introduced the antipsychotic drug Risperdal into interstate commerce for an unapproved use, rendering the product misbranded.
For most of this time period, Risperdal was approved only to treat schizophrenia, the Justice Department said.
Justice officials said in the press release that Janssens sales representatives promoted Risperdal to physicians and other prescribers who treated elderly dementia patients by urging the prescribers to use Risperdal to treat symptoms such as anxiety, agitation, depression, hostility and confusion.
The Justice Department said the company created written sales aids for use by Janssens ElderCare sales force that emphasized symptoms and minimized any mention of the FDA-approved use, treatment of schizophrenia.
The company also provided incentives for off-label promotion and intended use by basing sales representatives bonuses on total sales of Risperdal in their sales areas, not just sales for FDA-approved uses, Justice Department officials said in the release.
When pharmaceutical companies interfere with the FDAs mission of ensuring that drugs are safe and effective for the American public, they undermine the doctor-patient relationship and put the health and safety of patients at risk, Director of the FDAs Office of Criminal Investigations John Roth said in the press release.
Todays settlement demonstrates the governments continued focus on pharmaceutical companies that put profits ahead of the publics health. The FDA will continue to devote resources to criminal investigations targeting pharmaceutical companies that disregard the drug approval process and recklessly promote drugs for uses that have not been proven to be safe and effective.
The charges in this case were filed under the Federal Food, Drug, and Cosmetic Act (FDCA), which protects the health and safety of the public by ensuring, among other things, that drugs intended for use in humans are safe and effective for their intended uses and that the labeling of such drugs bear true, complete and accurate information, said Resource4thePeople.
The federal officials outlined the following procedures in their press release:
Under the FDCA, a pharmaceutical company must specify the intended uses of a drug in its new drug application to the FDA. Before approval, the FDA must determine that the drug is safe and effective for those specified uses.
Once the drug is approved, if the company intends a different use and then introduces the drug into interstate commerce for that new, unapproved use, the drug becomes misbranded. The unapproved use is also known as an off-label use because it is not included in the drugs FDA-approved labeling.
See more at: http://www.resource4thepeople.com/defectivedrugs/risperdal.html#sthash.yqpRM0P0.dpuf
Omega-3 provides health benefits and increased neural development for those suffering from dementia and memory loss, states Chemist Direct
London (PRWEB UK) 28 March 2014
Polyunsaturated fatty acids are an essential addition to a healthy diet, improving the chemical interaction of the nervous system with the brain along with regulating the blood flow and boosting the immune system.
Intensive research has gone into the function and benefits of these fatty acids, more commonly known as omega-3 due to the carbon bonding pattern found in this fat chain. Oily fish such as mackerel, salmon, char and sardines contain the best source of EPA, DPA and DHA. A different omega-3 source called ALA can be found in some nuts and seeds or in dark green leafy vegetables for vegetarian diets.
DHA is an essential ingredient to visual and neurological infant development and when taken as a supplement it can have a positive effect on the elderly, reducing many symptoms of aging. Many studies suggest an increase in omega-3 EPA and DHA supplements for those suffering from respiratory inflammation such as asthma or for those prone to allergic reactions.
These anti-inflammatory benefits also benefit patients with rheumatoid arthritis, minimising pain and stiffness in the joints, and stabilising those with diabetes 2. Surprisingly, studies have shown that cultures that have high fish consumption also show lower triglyceride levels, improved memory and learning skills, lower instances of depression, bipolar disorder and ADHD syndrome. http://bit.ly/1cCKXCZ
Last year a group of Chinese researchers compiled and published the results of n-3 PUFA on breast cancer development from over 20 global cohort studies on three continents, including Asia, Europe and the USA, in the British Medical Journal. http://bit.ly/1dIuaNz Investigating the effect of a high fish diet containing daily omega-3 intake on over 800,000 participants which included 20,000 instances of cancer, the team measured the risks of breast cancer and its relationship to omega-3 intake through blood samples.
Figures show a 14 percent deficit of cancer risk in those who had higher level of EPA and DHA in the blood and those with the lowest omega-3 levels showed the highest risk to cancer.
Omega-3 fatty acids found in fish oil also helps to maintain the nerve cells in the hippocampus, preserving the memory and keeping the brain from deteriorating with age leading to the development of Alzheimer’s disease and dementia.
In the January edition of Neurology (http://bit.ly/1loPLSh) Dr James Pottala, from the University of South Dakota in Sioux Falls, US discovered a 0.7% increase in overall brain size in those who doubled omega-3 intake.
The team researching the neural volume of 1,111 elderly women taking EPA and DHA over a period of eight years the team found 2.7 per cent size difference in the hippocampus area through MRI scanning. This was part of the US Women’s Health Initiative Memory Study that is looking for ways to minimise the risk of memory loss and dementia in the elderly.
Whether brain size plays a part in long-term development of dementia or not is still unknown, but with defined trails on the use of omega-3 on volunteers, further information can be gained on whether these supplements can help with protecting against cognitive decline.
Knoxville, TN (PRWEB) May 15, 2014
The connection between mind and body is undoubtedly strong. Physical activity has been shown to provide an abundance of mental health benefits. Brookhaven Retreat encourages women to participate in its various exercise programs that facilitate recovery from mental health and substance abuse issues.
Aerobic exercise improves blood circulation to the brain, which results in decreased immediate stress, and alleviates long-term depression. Just 30 minutes of exercise releases mood-enhancing endorphins. And it doesnt just reduce depression; according to a study published in the American Psychological Associations Monitor on Psychology, exercise reduces the frequency and intensity of anxiety in those more sensitive to anxiety-inducing situations.
Mental health illnesses such as bipolar disorder benefit greatly from structured activity to help manage daily life. Brookhaven Retreat encourages group activities such as volleyball and badminton, to help women develop leadership skills, trust and self-confidence. Adding diversity to a fitness routine helps prevent boredom. Dancing, gardening and walking are all part of a holistic approach to healing from mental health issues.
This May, Brookhaven Retreat introduced a new morning fitness class. This class focuses on outdoor aerobic exercise to improve cognitive skills, energy, mood and relaxation. Exercising in the morning provides added benefits including a metabolism boost, healthy sleep hygiene, fewer scheduling conflicts and a better diet throughout the day.
Negative symptoms of many mental health illnesses can often be reduced through physical fitness. Brookhaven Retreat believes the mind and body connection is undeniable, and incorporates physical wellness as an integral part of healing from mental illness.
About Brookhaven Retreat
Brookhaven Retreat is a women’s treatment center nestled on a naturally beautiful 48-acre site secluded in the foothills of the Great Smoky Mountains. It has helped hundreds of women across the United States overcome depression, trauma, anxiety, substance use and a range of other behavioral health challenges. Brookhavens Founder, Jacqueline Dawes, has predicated its gender-specific treatment on healing emotional breakage for women. In this way, she has established a sanctuary and a place where women can feel safe, secure and cared for by a staff of highly trained professionals.
Hey everyone. My name is Megan and I have been diagnosed with bipolar disorder. Here are most of my signs when I’m manic. A lot of the time it is hard to not…
Treating bipolar disorder (mania, depression, anxiety) with anti-psychotics and mood stabilisers.
Video Rating: 5 / 5
Omaha, Nebraska (PRWEB) June 03, 2014
The members of Cuddigan Law, P.C., L.L.O. are reaffirming their commitment to mental health sufferers nationwide by renewing their sponsorship of the annual National Alliance on Mental Illness (NAMI) Walks fundraiser on June 14. The nationwide NAMI Walks help raise awareness of the many forms of mental illness throughout the United States, promoting early intervention, continued research, and improved treatments. The organization relies on sponsorship and donations, providing all services at no cost to the public (1).
The Nevada Busing Scandal Calls Attention to Mistreatment of the Mentally Ill
While mistreatment of mentally ill patients has been occurring for years, the recent patient dumping scandal in Nevada has called attention to the tragic acts committed against suffering patients. In a CBS special report on mental health, Dan Rather revealed that Rawson-Neal Psychiatric Hospital in Las Vegas has allegedly been discharging mentally ill patients and sending them to California via one-way bus tickets instead of treating them (2). Many such patients had never been to California, had no family in the state, and were not given any follow-up treatment plans or housing arrangements. Investigators later discovered that Rawson-Neal, Nevadas primary hospital for the care of the mentally ill, similarly shipped over 1,500 psychiatric patients to other states in the past 5 years (3).
NAMI Takes Aim at Perception, Intervention, and Treatment
Scandals such as the one in Nevada are unfortunately common, leaving mental health victims to suffer in silence from the invisible disease. According to NAMIs website, one in four adult Americans experience a mental health disorder each year, and one in 17 suffers from a serious mental illness such as bipolar disorder, depression, or schizophrenia (4).
Members of the Cuddigan Law team annually support NAMI Nebraska by raising funds for the Walks, sponsoring walkers, mapping the walk route and assisting in set-up and registration. Timothy J. Cuddigan served as president of the organizations Nebraska chapter from 2009-2013, and remains a dedicated NAMI member (5). He can be contacted at http://www.cuddiganlaw.com or at (402) 933-5405.
Anyone is welcome to take part in the walk on June 14, 2014 at Elmwood Park in Omaha. Participants may register or donate at NAMI Walks Nebraska.